知镜 Cognispect · 医学文献与研究工作台

Reanalyzing a Randomized Controlled Trial of Invasive Aspergillosis Using a Desirability of Outcome Ranking Approach: Voriconazole Versus Amphotericin B Deoxycholate.

Zuniga-Moya JC, Araujo de Oliveira Santana M, Ostrosky-Zeichner L, Thompson GR, Walsh TJ, Spec A.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026-08-26 · PMID 42644615

文献摘要

Efficacy of antifungal therapy in invasive aspergillosis relies primarily on mortality, overlooking critical measures of treatment response. We used the Mycoses Study Group Education & Research Consortium (MSG) Desirability of Outcome Ranking (DOOR) framework to assess efficacy of antifungal therapies by integrating mortality, treatment failure, and severe adverse events. Voriconazole achieved better overall outcomes than amphotericin B using the DOOR approach.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。